Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: Relationship to antiepileptic property

Psychopharmacology

Volumn 207, Issue 4, 2010, Pages 513-527

  Higgins, Guy A ^a   Breysse, Nathalie ^a   Undzys, Elijus ^a   Derksen, D Richard ^a   Jeffrey, Melanie ^b   Scott, Brian W ^b   Xin, Tao ^a   Roucard, Corinne ^c   Bressand, Karine ^c   Depaulis, Antoine ^d   Burnham, W M ^b  

^a NPS Pharmaceuticals   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SynapCell   (France)

^d GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Attention; Cognition; Epilepsy; Five choice serial reaction time test; GAERS rat; Kindling; Translational medicine

Indexed keywords

ETIRACETAM; HARKOSERIDE; PHENYTOIN; PREGABALIN; VALPROATE SEMISODIUM; VALPROIC ACID;

ABSENCE; ACCURACY; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRIC SHOCK; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; SEIZURE; STIMULUS RESPONSE; TONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; ATTENTION; COGNITION; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SEIZURES;

EID: 72049099610     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1682-5     Document Type: Article

References (54)

1. Albright PS, Burnham WM (1980) Development of a new Pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 21:681-689
2. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2009) Progress report on new Epileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 83:1-43
3. Brodie MJ, McPhail E, Larkin JG, Gray JMB (1987) Psychomotor impairment and anticonvulsant therapy in adult epileptic patients. Eur J Clin Pharmacol 31:655-660 (Pubitemid 17020994)
4. Choi D, Stables JP, Kohn H (1996) Synthesis and anti-convulsant activities of N-benzyl 2-acetamidopropionamide derivatives. J Med Chem 39:1907-1916 (Pubitemid 26142830)
5. Cramer JA, Arrigo C, Van Hammee G, Gauer LJ, Cereghino JJ (2000) Effect of levetiracetam on epilepsy-related quality of life. N132 Study group. Epilepsia 41:868-874 (Pubitemid 30439579)
6. Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C (1998) Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 55:27-57 (Pubitemid 28231101)
7. Day M, Balci F, Wan HI, Fox GB, Rutkowski JL, Feuerstein G (2008) Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic. Curr Opin Invest Drugs 9:696-706 (Pubitemid 351950866)
8. Depaulis A, Van Luijtelaar G (2005) Genetic models of absence epilepsy in the rat. In: Pitkanen A, Schwartzkroin P, Moshe S (eds) Models of seizures and epilepsy, chapter 18. Elsevier, San Diego, p 233
9. Errington AC, Stohr T, Heers C, Lees G (2008) The investigational anticonvulsant Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 73:157-169 (Pubitemid 350294207)
10. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Carradini L, England S, Wilks J, Kinloch R, Hendrich J, Dolphin AC, Webb T, Williams D (2006) Identification of the alpha2- delta-1 subunit of voltage dependent calcium channels as a novel molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103:17537-17542 (Pubitemid 44789004)
11. Gomer B, Wagner K, Frings L, Saar J, Carius A, Härle M, Steinhoff BJ, Schulze-Bonhage A (2007) The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav 10:486-494 (Pubitemid 46567780)
12. Gower A, Hirsch E, Boehrer A, Noyer M, Marescaux C (1995) Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22:207-213
13. Gurbanova AA, Aker R, Berkman K, Onat FY, van Rijn CM, van Luijelaar G (2006) Effect of systemic and intracortical administration of phenytoin in two genetic models of absence epilepsy. Br J Pharmacol 148:1076-1082 (Pubitemid 44223013)
14. Higgins GA, Breysse N (2008) Rodent model of attention: the 5-choice serial reaction time task. Curr Protocols Pharmacol 5.49.1-5.49.20
15. Higgins GA, Breysse N, Undzys E, Quo C, Joharchi N, Derksen RD, Xin T, Isaac M, Slassi A (2009) The anti-epileptic drug lacosamide (Vimpat®) has anxiolytic property in rodents. Eur J Pharmacol (in press)
16. Hindmarch I, Trick L, Ridout F (2005) A double-blind, placebo- and positive-internal controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology 183:133-143 (Pubitemid 41609265)
17. Hurko O, Ryan JL (2005) Translational research in central nervous system drug discovery. NeuroRx 2:671-682 (Pubitemid 41393274)
18. Kaminski RM, Matagne A, Leclerq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H (2008) SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 54:715-720
19. Kaminski RM, Gillard M, Leclercq K, Hanon E, Lorent G, Dassesse D, Matagne A, Klitgaard H (2009) Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50:1729-1740
20. Klitgaard H, Matagne A, Gobert J, Wulfert E (1998) Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353:191-206 (Pubitemid 28352266)
21. Klitgaard H, Matagne A, Schachter SC, White HS (2008) Animal and translational models of the epilepsies. In: McArthur R, Borsini F (eds) Animal and translational models for CNS drug discovery, vol.2: neurological disorders. Academic, New York, pp. 311-335
22. LaRoche SM, Helmers SL (2004) The new antiepileptic drugs: clinical applications. JAMA 291:615-620 (Pubitemid 38500316)
23. Lees G, Stohr T, Errington AC (2006) Stereoselective effects of the novel anti-convulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology 50:98-110 (Pubitemid 43069776)
24. Lopez-Gongora M, Martinez-Domeno A, Garcia C, Escartin A (2008) Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. Epileptic Disord 10:297-305
25. Lothmann EW, Salerno RA, Perlin JB, Kaiser DL (1988) Screening and characterization of antiepileptic drugs with rapidly recurring hippocampal seizures in rats. Epilepsy Res 2:367-379
26. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Baijalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861-9866 (Pubitemid 38869327)
27. Matgane A, Margineanu DG, Kenda B, Michel P, Klitgaard H (2008) Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol 154:1662-1671
28. McNamara JO (1996) Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. McGrawHill, New York, pp 461-486
29. Meador KJ, Loring DW, Moore EE, Thompson WO, Nichols ME, Oberzan RE, Durkin MW, Gallagher BB, King DW (1995) Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 45:1494-1499
30. Meador KJ, Gilliam FG, Kanner AM, Pellock JM (2001) Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2:SS1-SS17
31. Mecarelli O, Vicenzini E, Pulitano P, Vanacore N, Romolo FS, Di Piero V, Lenzi GL, Accornero N (2004) Clinical, cognitive and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother 38:1816-1822 (Pubitemid 39425714)
32. Meldrum BS, Rogawski MA (2007) Molecular targets for antiepileptic drug development. Neurotherapeutics 4:18-61 (Pubitemid 46107329)
33. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
34. Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16:695-714
35. Perucca E, French J, Bialer M (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurology 6:793-804 (Pubitemid 47243712)
36. Perucca E, Yasothan U, Clincke G, Kirkpatrick P (2008) Lacosamide. Nature Rev Drug Discovery 7:973-974
37. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R (2006) Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res 68:181-188 (Pubitemid 43295432)
38. Pinel JP, Skelton R, Mucha RF (1976) Kindling related changes in afterdischarge "thresholds". Epilepsia 17:197-206
39. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogy Clin Neurophysiol 32:281-294
40. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
41. Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69:273-294 (Pubitemid 44209049)
42. Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Med 10:685-692 (Pubitemid 38937632)
43. Rundfeldt C, Loscher W (1993) Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats. J Pharm Exp Ther 236:216-223 (Pubitemid 23315650)
44. Salinsky MC, Oken BS, Binder LM (1996) Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia 37:181-187 (Pubitemid 26043797)
45. Schmidt D (2002) The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy Res 50:1-12
46. Shannon HE, Love PL (2004) Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav 5:857-865
47. Shannon HE, Love PL (2005) Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats. Epilepsy Behav 7:620-628
48. Sheets PL, Heers C, Stoehr T, Cummins TR (2008) Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharm Exp Ther 326:89-99 (Pubitemid 351872141)
49. Stoehr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS (2007) Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res 74:147-154 (Pubitemid 46654745)
50. Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137-150
51. Upton N (1994) Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. TIPS 15:456-463
52. Vartanian MG, Radulovic LL, Kinsora JJ, Serpa KA, Vergnes M, Bertram E, Taylor CP (2006) Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 68:189-205 (Pubitemid 43295433)
53. Vermeulen J, Aldenkamp AP (1995) Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22:65-95
54. White HS, Woodhead JH, Franklin MR, Swinyard EA, Wolf HH (1995) Experimental selection, quantification, and evaluation of Antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs, 4th edn. Raven, New York, pp 99-110